Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Neurogen Corporation - Financial and Strategic Analysis Review' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Ligand Pharmaceuticals, Inc. – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 100% |
| Biotechnology (Pharmaceuticals) Report - Global Business Performance Analysis |
Aug 2011 | £950 | 74% |
- Results 1 - 2 of 2
-
-
- 1
-
-
